Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Steven Finkbeiner
Based on 5 articles published since 2008
||||
Expertise Level
The expertise of Steven Finkbeiner ranks in the
  • Top 6.6%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 5 articles on the topic.
Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    University of California San Francisco   Contact    
2018
  • Gladstone Institutes, the Taube/Koret Center for Neurodegenerative Disease, San Francisco, CA, 94158, USA. · Gladstone Institutes, the Taube/Koret Center for Neurodegenerative Disease, San Francisco, CA, 94158, USA. · Department of Neurology, University of California, San Francisco, CA, 94143, USA. · Department Physiology, University of California, San Francisco, CA, 94143, USA. · Graduate Programs in Neuroscience and Biomedical Sciences, University of California, San Francisco, CA, 94143, USA. · Pubmed 29234887
2017
  • Gladstone Institute of Neurological Disease, San Francisco, CA 94158. · The Taube/Koret Center for Neurodegenerative Disease Research, San Francisco, CA 94158. · The Hellman Foundation Program in Alzheimer's Disease Research, San Francisco, CA 94158. · Biomedical Sciences Graduate Program, University of California, San Francisco, CA 94143. · Medical Scientist Training Program, University of California, San Francisco, CA 94143. · Program in Bioengineering, University of California, San Francisco, CA 94143. · Department of Statistics, Penn State University, State College, PA 16802. · Gladstone Institute of Neurological Disease, San Francisco, CA 94158; · Department of Neurology, University of California, San Francisco, CA 94143. · Department of Physiology, University of California, San Francisco, CA 94143. · Graduate Programs in Neuroscience, University of California, San Francisco, CA 94143. · Pubmed 28028237
2014
  • Department of Chemistry, University of Cambridge, Cambridge, United Kingdom ; Elan Pharmaceuticals, South San Francisco, California, United States of America. · Elan Pharmaceuticals, South San Francisco, California, United States of America. · Department of Chemistry, University of Cambridge, Cambridge, United Kingdom ; SEDIPFAR (Servicio De Descubrimiento, Diseño Y Desarrollo Pre-Clínico De Fármacos De La Argentina) drug discovery platform, Universidad Nacional de Rosario, Rosario, Argentina. · Department of Chemistry, University of Cambridge, Cambridge, United Kingdom. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana, United States of America. · Gladstone Institute of Neurological Disease, San Francisco, California, United States of America ; Taube-Koret Center for Neurodegenerative Disease Research, The Consortium for Frontotemporal Dementia Research, and The Hellman Family Foundation Program for Alzheimer's Disease Research, San Francisco, California, United States of America. · Gladstone Institute of Neurological Disease, San Francisco, California, United States of America ; Taube-Koret Center for Neurodegenerative Disease Research, The Consortium for Frontotemporal Dementia Research, and The Hellman Family Foundation Program for Alzheimer's Disease Research, San Francisco, California, United States of America ; Departments of Neurology and Physiology, UCSF, San Francisco, California, United States of America. · Department of Structural & Molecular Biology, University College London, London, United Kingdom. · Pubmed 24551051
2014
  • Gladstone Institute of Neurological Disease, the Taube-Koret Center for Neurodegenerative Disease Research, and the Hellman Family Foundation Program in Alzheimer's Disease Research, San Francisco, California 94158, Departments of Neurology, Physiology, and Graduate Programs in Neuroscience and Biomedical Sciences, University of California, San Francisco, California 94158, and Laboratory of Neurogenetics, National Institutes of Health, Bethesda, Maryland 20892. · Pubmed 24403142
2011
  • Department of Neurology and Physiology, University of California, San Francisco, California 94158, USA. · Pubmed 21489994
Probable:    Miscellaneous institutions in San Francisco      
2017
  • Gladstone Institute of Neurological Disease, San Francisco, CA 94158. · The Taube/Koret Center for Neurodegenerative Disease Research, San Francisco, CA 94158. · The Hellman Foundation Program in Alzheimer's Disease Research, San Francisco, CA 94158. · Biomedical Sciences Graduate Program, University of California, San Francisco, CA 94143. · Medical Scientist Training Program, University of California, San Francisco, CA 94143. · Program in Bioengineering, University of California, San Francisco, CA 94143. · Department of Statistics, Penn State University, State College, PA 16802. · Gladstone Institute of Neurological Disease, San Francisco, CA 94158; · Department of Neurology, University of California, San Francisco, CA 94143. · Department of Physiology, University of California, San Francisco, CA 94143. · Graduate Programs in Neuroscience, University of California, San Francisco, CA 94143. · Pubmed 28028237
Possible:    National Institutes of Health      
2014
  • Gladstone Institute of Neurological Disease, the Taube-Koret Center for Neurodegenerative Disease Research, and the Hellman Family Foundation Program in Alzheimer's Disease Research, San Francisco, California 94158, Departments of Neurology, Physiology, and Graduate Programs in Neuroscience and Biomedical Sciences, University of California, San Francisco, California 94158, and Laboratory of Neurogenetics, National Institutes of Health, Bethesda, Maryland 20892. · Pubmed 24403142
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Steven Finkbeiner in 2008-2019 about Parkinson Disease:

  • iPS cells in the study of PD molecular pathogenesis. 2018
  • Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis. 2017
  • Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease. 2014
  • Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. 2014
  • Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. 2011
Show List of Full Article Records
Google Searches

Learn more about Steven Finkbeiner using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of California San Francisco
Miscellaneous institutions in San Francisco
National Institutes of Health
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of California San Francisco
2018
  • Gladstone Institutes, the Taube/Koret Center for Neurodegenerative Disease, San Francisco, CA, 94158, USA. · Gladstone Institutes, the Taube/Koret Center for Neurodegenerative Disease, San Francisco, CA, 94158, USA. · Department of Neurology, University of California, San Francisco, CA, 94143, USA. · Department Physiology, University of California, San Francisco, CA, 94143, USA. · Graduate Programs in Neuroscience and Biomedical Sciences, University of California, San Francisco, CA, 94143, USA. · Pubmed 29234887
2017
  • Gladstone Institute of Neurological Disease, San Francisco, CA 94158. · The Taube/Koret Center for Neurodegenerative Disease Research, San Francisco, CA 94158. · The Hellman Foundation Program in Alzheimer's Disease Research, San Francisco, CA 94158. · Biomedical Sciences Graduate Program, University of California, San Francisco, CA 94143. · Medical Scientist Training Program, University of California, San Francisco, CA 94143. · Program in Bioengineering, University of California, San Francisco, CA 94143. · Department of Statistics, Penn State University, State College, PA 16802. · Gladstone Institute of Neurological Disease, San Francisco, CA 94158; · Department of Neurology, University of California, San Francisco, CA 94143. · Department of Physiology, University of California, San Francisco, CA 94143. · Graduate Programs in Neuroscience, University of California, San Francisco, CA 94143. · Pubmed 28028237
2014
  • Department of Chemistry, University of Cambridge, Cambridge, United Kingdom ; Elan Pharmaceuticals, South San Francisco, California, United States of America. · Elan Pharmaceuticals, South San Francisco, California, United States of America. · Department of Chemistry, University of Cambridge, Cambridge, United Kingdom ; SEDIPFAR (Servicio De Descubrimiento, Diseño Y Desarrollo Pre-Clínico De Fármacos De La Argentina) drug discovery platform, Universidad Nacional de Rosario, Rosario, Argentina. · Department of Chemistry, University of Cambridge, Cambridge, United Kingdom. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana, United States of America. · Gladstone Institute of Neurological Disease, San Francisco, California, United States of America ; Taube-Koret Center for Neurodegenerative Disease Research, The Consortium for Frontotemporal Dementia Research, and The Hellman Family Foundation Program for Alzheimer's Disease Research, San Francisco, California, United States of America. · Gladstone Institute of Neurological Disease, San Francisco, California, United States of America ; Taube-Koret Center for Neurodegenerative Disease Research, The Consortium for Frontotemporal Dementia Research, and The Hellman Family Foundation Program for Alzheimer's Disease Research, San Francisco, California, United States of America ; Departments of Neurology and Physiology, UCSF, San Francisco, California, United States of America. · Department of Structural & Molecular Biology, University College London, London, United Kingdom. · Pubmed 24551051
2014
  • Gladstone Institute of Neurological Disease, the Taube-Koret Center for Neurodegenerative Disease Research, and the Hellman Family Foundation Program in Alzheimer's Disease Research, San Francisco, California 94158, Departments of Neurology, Physiology, and Graduate Programs in Neuroscience and Biomedical Sciences, University of California, San Francisco, California 94158, and Laboratory of Neurogenetics, National Institutes of Health, Bethesda, Maryland 20892. · Pubmed 24403142
2011
  • Department of Neurology and Physiology, University of California, San Francisco, California 94158, USA. · Pubmed 21489994
Miscellaneous institutions in San Francisco
2017
  • Gladstone Institute of Neurological Disease, San Francisco, CA 94158. · The Taube/Koret Center for Neurodegenerative Disease Research, San Francisco, CA 94158. · The Hellman Foundation Program in Alzheimer's Disease Research, San Francisco, CA 94158. · Biomedical Sciences Graduate Program, University of California, San Francisco, CA 94143. · Medical Scientist Training Program, University of California, San Francisco, CA 94143. · Program in Bioengineering, University of California, San Francisco, CA 94143. · Department of Statistics, Penn State University, State College, PA 16802. · Gladstone Institute of Neurological Disease, San Francisco, CA 94158; · Department of Neurology, University of California, San Francisco, CA 94143. · Department of Physiology, University of California, San Francisco, CA 94143. · Graduate Programs in Neuroscience, University of California, San Francisco, CA 94143. · Pubmed 28028237
National Institutes of Health
2014
  • Gladstone Institute of Neurological Disease, the Taube-Koret Center for Neurodegenerative Disease Research, and the Hellman Family Foundation Program in Alzheimer's Disease Research, San Francisco, California 94158, Departments of Neurology, Physiology, and Graduate Programs in Neuroscience and Biomedical Sciences, University of California, San Francisco, California 94158, and Laboratory of Neurogenetics, National Institutes of Health, Bethesda, Maryland 20892. · Pubmed 24403142
Yearly article counts 011002001000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.